Claim 20% Off Global Market Reports With Code ONLINE20 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

How Big Is The Preeclampsia Drugs Market Today And What Is Its Future Size?

The market size for preeclampsia drugs has witnessed considerable growth in the last few years. Projected growth is from $1.25 billion in 2024 to $1.37 billion in 2025, representing a compound annual growth rate (CAGR) of 9.6%. Factors contributing to this growth during the historic period include enhanced maternal health awareness, intensified research and development, concerns surrounding neonatal health, and advancements in early detection.

Rapid expansion is predicted for the preeclampsia drugs market in the coming years. The market is projected to reach “$2.1 billion in 2029 with a compound annual growth rate (CAGR) of 11.2%. The projected growth during this prediction period can be accredited to personalized medicine, non-invasive diagnostic instruments, targeted treatments, and health equality initiatives. Preventive strategies, patient-focused care, continuous supervision, and regulatory emphasis are among the significant trends anticipated during the forecast period.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13025&type=smp

What Underlying Factors Are Supporting The Preeclampsia Drugs Market Growth?

Anticipated market growth for preeclampsia drugs is closely linked to the increase in diabetes incidents among expectant mothers. Diabetes, a chronic metabolic disorder, is often marked by heightened blood sugar levels. Preeclampsia, another severe condition frequently experienced during pregnancy, is associated with raised blood pressure and organ damage. Pregnant women with preterm preeclampsia often take Metformin, a drug used to treat this condition. In December 2022, records from the National Library of Medicine, a renowned US-based biomedical library and hub for biomedical informatics, showed an increase of 6.56% in Gestational Diabetes Mellitus (GDM) cases with an absolute number of 20,865 recorded incidents for the year. As such, the increasing occurrence of diabetes among pregnant women presents a significant driving force for the preeclampsia drug market.

How Is The Global Preeclampsia Drugs Market Broken Down By Segment?

The preeclampsia drugs market covered in this report is segmented –

1) By Type: Mild Preeclampsia, Severe Preeclampsia

2) By Treatment: Medication to Lower Hypertension (B.P), Corticosteroids, Anticonvulsants Medication

3) By Route of Administration: Oral, Parenteral, Other Route of Administration

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacies, Other Distribution Channels

5) By End-User: Hospitals, Specialty Clinics, Diagnostic Centers, Other End-Users

Subsegments:

1) By Mild Preeclampsia: Blood Pressure Management, Proteinuria Monitoring, Lifestyle Modifications

2) By Severe Preeclampsia: Antihypertensive Medications, Magnesium Sulfate Therapy, Emergency Delivery Management

Which Trends Are Likely To Redefine Growth Paths In The Preeclampsia Drugs Market?

Leading players in the preeclampsia medicine market are concentrating on the development of advanced drug solutions to strengthen their market standing. For example, Comanche Biopharma Corp., an American biopharmaceutical company, announced in March 2023 that their unique siRNA treatment, CBP-4888 for preeclampsia, had received approval for an investigational new drug (IND) application by the Food and Drug Administration (FDA). Administered subcutaneously, CBP-4888 is a siRNA therapy that diminishes the production of soluble fms-like tyrosine kinase-1 (sFLT1) in the placenta. The overproduction of the sFLT1 protein by the placenta, which then enters the maternal bloodstream, is primarily responsible for preeclampsia. Symptoms of preeclampsia such as elevated blood pressure and organ damage can be mitigated by CBP-4888, potentially allowing for a safe extension of the pregnancy period.

Which Firms Are Making The Biggest Impact In The Preeclampsia Drugs Market?

Major companies operating in the preeclampsia drugs market are AbbVie Inc., Pfizer Inc., Johnson & Johnson Co, F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Novartis AG, Sanofi S.A., Celgene Corp, Thermo Fisher Scientific Inc., AstraZeneca PLC, Abbott Laboratories, GlaxoSmithKline PLC, Takeda Pharmaceuticals Company Limited, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Siemens Healthcare GmbH, Boehringer Ingelheim Group, Viatris Inc., Baxter International Inc., Teva Pharmaceutical Industries Ltd., Union Chimique Belge SA, Otsuka Pharmaceutical Co. Ltd., Kyowa Kirin Co Ltd., Mallinckrodt Pharmaceuticals Limited, Comanche Biopharma Corp, Genentech Inc., Diabetomics Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/preeclampsia-drugs-global-market-report

Which Geographic Regions Are Creating Strong Demand In The Preeclampsia Drugs Market?

North America was the largest region in the preeclampsia drugs market in 2024. The regions covered in preeclampsia drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=13025&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model